(Q40413348)

English

Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Juan-Manuel Sancho

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

José Domínguez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Montserrat Giménez

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Josep-Maria Ribera

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

object named as

Cristina Prat

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Christelle Ferra

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Silvia Blanco

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1752-1761

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661397%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Serum and plasma parameters in clinical evaluation of neutropenic fever

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Risk assessment and treatment of low-risk patients with febrile neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

C-reactive protein and fever in neutropenic patients.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Procalcitonin and neopterin correlation with aetiology and severity of pneumonia

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Procalcitonin concentrations in patients with neutropenic fever

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Biomarkers of sepsis: clinically useful?

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190802258956

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40413348&oldid=1760579354"